VistaGen Therapeutics Inc - ESG Rating & Company Profile powered by AI
If you work at VistaGen Therapeutics Inc and you wish to use your ESG aseessment, please get in touch. This webpage of VistaGen Therapeutics Inc was prepared by All Street Sevva using advanced Cognitive Robots. This page contains a zero-cost Sustainability analysis covering VistaGen Therapeutics Inc.
VistaGen Therapeutics Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.5; made up of an environmental score of 4.0, social score of 4.8 and governance score of 4.8.
4.5
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 852 | Vaccibody AS | 4.6 | High |
| 852 | argenx SE | 4.6 | High |
| 868 | VistaGen Therapeutics Inc | 4.5 | High |
| 868 | CARsgen Therapeutics Holdings Ltd | 4.5 | High |
| 868 | Boiron SA | 4.5 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does VistaGen Therapeutics Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes VistaGen Therapeutics Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes VistaGen Therapeutics Inc report the average age of the workforce?
Sign up for free to unlockDoes VistaGen Therapeutics Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes VistaGen Therapeutics Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes VistaGen Therapeutics Inc disclose cybersecurity risks?
Sign up for free to unlockDoes VistaGen Therapeutics Inc offer flexible work?
Sign up for free to unlockDoes VistaGen Therapeutics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes VistaGen Therapeutics Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes VistaGen Therapeutics Inc conduct supply chain audits?
Sign up for free to unlockDoes VistaGen Therapeutics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes VistaGen Therapeutics Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes VistaGen Therapeutics Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes VistaGen Therapeutics Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes VistaGen Therapeutics Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes VistaGen Therapeutics Inc disclose water use targets?
Sign up for free to unlockDoes VistaGen Therapeutics Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid VistaGen Therapeutics Inc have a product recall in the last two years?
Sign up for free to unlockDoes VistaGen Therapeutics Inc disclose incidents of discrimination?
Sign up for free to unlockDoes VistaGen Therapeutics Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas VistaGen Therapeutics Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes VistaGen Therapeutics Inc disclose parental leave metrics?
Sign up for free to unlockDoes VistaGen Therapeutics Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes VistaGen Therapeutics Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes VistaGen Therapeutics Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes VistaGen Therapeutics Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes VistaGen Therapeutics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes VistaGen Therapeutics Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs VistaGen Therapeutics Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes VistaGen Therapeutics Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes VistaGen Therapeutics Inc disclose its waste policy?
Sign up for free to unlockDoes VistaGen Therapeutics Inc report according to TCFD requirements?
Sign up for free to unlockDoes VistaGen Therapeutics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes VistaGen Therapeutics Inc disclose energy use targets?
Sign up for free to unlockDoes VistaGen Therapeutics Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes VistaGen Therapeutics Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for VistaGen Therapeutics Inc
These potential risks are based on the size, segment and geographies of the company.
VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III development for the acute treatment of anxiety in adults with social anxiety disorder. Its PH94B product candidature also has potential to treat a range of anxiety disorders, including adjustment disorder with anxiety, postpartum anxiety, post-traumatic stress disorder, preprocedural anxiety, and panic disorders. The company's CNS pipeline also comprises PH10, a rapid-onset neuroactive nasal spray, which is in preparation for Phase 2B clinical development as a stand-alone treatment for major depressive disorder (MDD); and AV-101, an oral N-methyl-D-aspartate receptor antagonist, which is in development in combination with oral probenecid as a potential treatment of levodopa-induced dyskinesia, MDD, neuropathic pain, and suicidal ideation. It has contract research and development agreement with Cato Research Ltd.; license agreement with Pherin Pharmaceuticals, Inc.; and license and collaboration agreement with EverInsight Therapeutics Inc. VistaGen Therapeutics, Inc. was founded in 1998 and is headquartered in South San Francisco, California.